Systemic and topical antibiotics for chronic rhinosinusitis

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 12, 2015, Pages

  Chong, Lee Yee ^a   Head, Karen ^a   Hopkins, Claire ^b   Philpott, Carl ^c   Burton, Martin J ^a  

^a UK COCHRANE CENTRE   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CLARITHROMYCIN; CLAVULANIC ACID; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; NASAL LAVAGE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 84964431495     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011994     Document Type: Article

References (34)

1. Bucher HC, Tschudi P, Young J, Périat P, Welge-Lüussen A, Züst H, et al. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Archives of Internal Medicine 2004;163(15):1793-8.
2. Cho SH, Hong SJ, Han B, Lee SH, Suh L, Norton J, et al. Age-related differences in the pathogenesis of chronic rhinosinusitis. Journal of Allergy and Clinical Immunology 2012;129(3):858-60.e2.
3. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Different types of intranasal steroids for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.
4. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.
5. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Short-course oral steroids alone for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.
6. Chong LY, Head K, Hopkins C, Philpott C, Schilder AGM. Saline irrigation for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.
7. Chong LY, Head K, Hopkins C, Philpott C, Burton MJ. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis [Protocol]. Cochrane Database of Systematic Reviews in press.
8. DeMarcantonio MA, Han JK. Nasal polyps: pathogenesis and treatment implications. Otolaryngologic Clinics of North America 2011;44(3):685-95, ix.
9. Ebbens FA, Toppila-Salmi SK, Renkonen JA, Renkonen RL, Mullol J, van Drunen CM, et al. Endothelial L-selectin ligand expression in nasal polyps. Allergy 2010;65(1):95-102.
10. Ebbens FA, Toppila-Salmi S, de Groot EJ, Renkonen J, Renkonen R, van Drunen CM, et al. Predictors of post-operative response to treatment: a double blind placebo controlled study in chronic rhinosinusitis patients. Rhinology 2011;49(4):413-9.
11. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629-34. [PUBMED: 9310563]
12. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 2007;45(Suppl 20):1-139.
13. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngology - Head and Neck Surgery 1995;113(1):104-9.
14. Gulliford MC, Dregan A, Moore MV, Ashworth M, Staa Tv, McCann G, et al. Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 UK general practices. BMJ Open 2014;4(10):e006245.
15. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
16. 2LEN study. Allergy 2011;66(9):1216-23.
17. Hatipoglu U, Rubinstein I. Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm. Current Allergy and Asthma Reports 2005;5:491-4.
18. Inamura K, Ohta N, Fukase S, Kasajima N, Aoyagi M. The effect of erythromycin on human peripheral neutrophil apoptosis. Rhinology 2000;38:124-9.
19. Kern RC, Conley DB, Walsh W, Chandra R, Kato A, Tripathi-Peters A, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. American Journal of Rhinology 2008;22(6):549-59.
20. Keswani A, Chustz RT, Suh L, Carter R, Peters AT, Tan BK, et al. Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps. Allergy 2012;67(1):25-32.
21. Larsen P, Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope 2004;114(4):710-9.
22. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Archives of Family Medicine 2000;9(8):722-6.
23. Miyanohara T, Ushikai M, Matsune S, Ueno K, Katahira S, Kurono Y. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblasts. Laryngoscope 2000;110:126-31.
24. Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database of Systematic Reviews 2011, Issue 5. [DOI: 10.1002/14651858.CD008233.pub2]
25. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114(5):923-30.
26. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology 2010;48(3):305-11.
27. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
28. Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology 2011;128(6):1198-206.e1.
29. Tomassen P, Van Zele T, Zhang N, Perez-Novo C, Van Bruaene N, Gevaert P, et al. Pathophysiology of chronic rhinosinusitis. Proceedings of the American Thoracic Society 2011;8(1):115-20.
30. van Drunen CM, Reinartz SM, Wigman J, Fokkens W. Inflammation in chronic rhinosinusitis and nasal polyposis. Immunology and Allergy Clinics of North America 2009;29(4):621-9.
31. Wallwork B, Coman W, Mackay SA, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116;2:189-93.
32. Wozniak DJ, Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004;125:62S-9S.
33. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. Journal of Allergy and Clinical Immunology 2008;122(5):961-8.
34. Zhang XH, Lu X, Long XB, You XJ, Gao QX, Cui YH, et al. Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper. Clinical and Experimental Allergy 2009;39(5):647-54.